In this review, we discuss surgical treatment options for patients with breast cancer known to have a high-penetrant cancer-predisposing gene, like the BRCA1 and BRCA2, and address the oncological safety of less aggressive surgical options, for both patients and unaffected carriers. The gene discussed is BRCA2; the disease is breast carcinoma.